中航飛機(000768.SZ):相關委託貸款本金和收益已到期收回
格隆匯11月27日丨中航飛機(000768.SZ)公佈,公司於2018年3月9日召開第七屆董事會第十四次會議,審議批准了《關於繼續為貴州新安航空機械有限責任公司提供委託貸款的議案》,同意公司向全資子公司貴州新安航空機械有限責任公司發放6450萬元循環額度委託貸款,總貸款額度期限一年。貸款利率按不高於銀行同期基準利率收取。
按照上述董事會決議,公司通過北京銀行股份有限公司西安分行營業部向貴州新安航空機械有限責任公司累計發放委託貸款人民幣6450萬元,貸款期限為一年,貸款年利率為3.915%。
截至2019年11月26日,上述委託貸款本金和收益已按合同約定全部到期收回。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.